Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIIOngoingD-0838-2026

Drug recall · September 9, 2026

Revcovi recall

Why: Failed Stability Specifications: Out of specification stability result for the protein concentration profile.

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For Intramuscular Use Only, Mfd. by Chiesi USA, Inc., Cary, NC 27518, NDC 10122-502-01

Lots / codes

Lot#: 1221973, Exp 3/24/2027

Quantity
3,002 vials
Company
Chiesi USA, Inc., Cary, NC
Distribution
MO, TN
Initiated
August 19, 2026 · Voluntary: Firm initiated
Classified
September 11, 2026
Reported
September 9, 2026
How notified
Letter

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.